Jon E. Angell

Array ( [id] => 6602353 [patent_doc_number] => 20100062951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'siRNA targeting TIE-2' [patent_app_type] => utility [patent_app_number] => 12/586167 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35970 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062951.pdf [firstpage_image] =>[orig_patent_app_number] => 12586167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568084 [patent_doc_number] => 20110288147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop' [patent_app_type] => utility [patent_app_number] => 12/586283 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29653 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288147.pdf [firstpage_image] =>[orig_patent_app_number] => 12586283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375801 [patent_doc_number] => 08680065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use' [patent_app_type] => utility [patent_app_number] => 13/062858 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 19445 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351333 [patent_doc_number] => 20100249210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO DLK-1 AND THE P38 MAPK PATHWAY IN NERVE REGENERATION' [patent_app_type] => utility [patent_app_number] => 12/558296 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22635 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249210.pdf [firstpage_image] =>[orig_patent_app_number] => 12558296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14037 [patent_doc_number] => 07807819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'siRNA targeting survivin' [patent_app_type] => utility [patent_app_number] => 12/584705 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 28773 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807819.pdf [firstpage_image] =>[orig_patent_app_number] => 12584705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483979 [patent_doc_number] => 20100008981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHODS AND SEQUENCES TO SUPPRESS PRIMATE HUNTINGTON GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/556888 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13824 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008981.pdf [firstpage_image] =>[orig_patent_app_number] => 12556888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544164 [patent_doc_number] => 20100125100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'GOLD NANOROD-siRNA COMPLEXES AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/555609 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125100.pdf [firstpage_image] =>[orig_patent_app_number] => 12555609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6605850 [patent_doc_number] => 20100063134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'TREATMENT OF NEURODEGENERATIVE DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA' [patent_app_type] => utility [patent_app_number] => 12/549110 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12322 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063134.pdf [firstpage_image] =>[orig_patent_app_number] => 12549110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328680 [patent_doc_number] => 08236774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Human telomerase catalytic subunit' [patent_app_type] => utility [patent_app_number] => 12/545774 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 123 [patent_no_of_words] => 102922 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12545774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777749 [patent_doc_number] => 08852954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Nucleic acid molecule having binding affinity to rodent-derived IgG antibody, binder, detection reagent, and detection kit' [patent_app_type] => utility [patent_app_number] => 13/511618 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 9038 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086357 [patent_doc_number] => 08557786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Micro RNA (MiRNA) and neurofibromatosis type 1: a role in diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 13/059862 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 27 [patent_no_of_words] => 28683 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973254 [patent_doc_number] => 20110152357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma' [patent_app_type] => utility [patent_app_number] => 13/058662 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22703 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152357.pdf [firstpage_image] =>[orig_patent_app_number] => 13058662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479549 [patent_doc_number] => 20100092486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'MODULATION OF MYELOID DIFFERENTATION PRIMARY RESPONSE GENE 88 (MYD88) EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/537354 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10905 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092486.pdf [firstpage_image] =>[orig_patent_app_number] => 12537354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488843 [patent_doc_number] => 20110236972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/057741 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41830 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236972.pdf [firstpage_image] =>[orig_patent_app_number] => 13057741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959659 [patent_doc_number] => 20110184046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Compositions And Methods For Inhibiting Expression Of GSK-3 Genes' [patent_app_type] => utility [patent_app_number] => 13/003740 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 73593 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184046.pdf [firstpage_image] =>[orig_patent_app_number] => 13003740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487457 [patent_doc_number] => 20110251130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Methods and Compositions for Promoting Bone Growth' [patent_app_type] => utility [patent_app_number] => 13/001614 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 48018 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251130.pdf [firstpage_image] =>[orig_patent_app_number] => 13001614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256543 [patent_doc_number] => 20100029501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'METHOD OF IDENTIFYING MICRO-RNA TARGETS' [patent_app_type] => utility [patent_app_number] => 12/496481 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 22582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029501.pdf [firstpage_image] =>[orig_patent_app_number] => 12496481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712094 [patent_doc_number] => 20120004276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF EXPRESSION OF MITOCHONDRIAL GLYCEROL-3 PHOSPHATE ACYLTRANSFERASE 1 (MTGPAT1)' [patent_app_type] => utility [patent_app_number] => 13/000974 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20660 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6585826 [patent_doc_number] => 20100047890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR GENERATING SPORULATION DEFICIENT BACTERIA' [patent_app_type] => utility [patent_app_number] => 12/485636 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10948 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047890.pdf [firstpage_image] =>[orig_patent_app_number] => 12485636 [rel_patent_id] =>[rel_patent_doc_number] =>)